Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer

Westbrook, J.A., Wood, S.L., Cairns, D.A. et al. (14 more authors) (2019) Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer. The Journal of Pathology, 247 (3). pp. 381-391. ISSN 0022-3417

Abstract

Metadata

Authors/Creators:
  • Westbrook, J.A.
  • Wood, S.L.
  • Cairns, D.A.
  • McMahon, K.
  • Gahlaut, R.
  • Thygesen, H.
  • Shires, M.
  • Roberts, S.
  • Marshall, H.
  • Oliva, M.
  • Dunning, M.J.
  • Hanby, A.M.
  • Selby, P.J.
  • Speirs, V.
  • Mavria, G.
  • Coleman, R.E.
  • Brown, J.
Copyright, Publisher and Additional Information: © 2018 Pathological Society of Great Britain and Ireland.
Keywords: DOCK4; Bone metastasis; breast cancer; biomarker; proteomics
Dates:
  • Accepted: 30 October 2018
  • Published (online): 14 November 2018
  • Published: March 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 07 Nov 2018 14:54
Last Modified: 13 Feb 2019 15:51
Published Version: https://doi.org/10.1002/path.5197
Status: Published
Publisher: Wiley
Refereed: Yes
Identification Number: https://doi.org/10.1002/path.5197

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics